Ceribell Inc.
Clinical trials sponsored by Ceribell Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New brain monitor aims to catch ICU delirium earlier Results expected Oct 2026 (estimated)
- Portable EEG device probes delirium risk in ICU patients Results expected Dec 2026 (estimated)
-
New brain monitor aims to catch ICU delirium earlier
Knowledge-focused Recruiting nowThis study tests a new monitor (Ceribell) to see if it can help doctors spot delirium in ICU patients sooner than standard checks. About 100 adults in the ICU will take part. The goal is to see if earlier detection leads to better treatment decisions.
Sponsor: Ceribell Inc. • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Portable EEG device probes delirium risk in ICU patients
Knowledge-focused Recruiting nowThis study aims to find out how common certain brain wave abnormalities are in adult ICU patients who are at high risk for delirium. Researchers will use a portable EEG device to monitor 100 patients in medical, surgical, and cardiovascular ICUs. The goal is to better understand …
Sponsor: Ceribell Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC